STOCK TITAN

Kamada (KMDA) Form 4 Filings

KMDA NASDAQ

Here are the Form 4 insider transactions from Kamada Ltd (KMDA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow KMDA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KMDA filings page.

Rhea-AI Summary

Kamada Ltd VP Quality Yael Brenner reported compensation-related option adjustments rather than open‑market trades. On April 7, 2026, she was granted several tranches of employee stock options for 15,000 underlying ordinary shares, held indirectly by a trustee under the company’s 2011 Share Award Plan.

The filing shows paired entries where options with exercise prices of $6.12 and $7.50 were disposed of to the issuer and replaced with options at adjusted exercise prices of $5.87 and $7.25. A footnote explains the exercise prices were adjusted under the plan following a cash dividend declared on March 11, 2026, with no other changes to award terms. The options vest in four equal annual installments.

Rhea-AI Summary

Kamada Ltd. director Payorski Lilach reported administrative option changes involving employee stock options held by a trustee under the company’s 2011 Share Award Plan. The filing shows four grant/award acquisitions and four dispositions to the issuer, each for 7,500 options over Ordinary Shares.

The options carry exercise prices of $5.87 or $6.12 per share and expire on June 22, 2029. Footnotes state the exercise prices were adjusted under the plan following a cash dividend declared on March 11, 2026, and that all U.S. dollar exercise prices reflect a conversion from NIS. The options vest in four equal annual installments, with 25% vesting on each anniversary of the grant date.